SCHEMBL4941277

SCHEMBL4941277

CC1=C[C]CC=C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1141344 0.58
SCHEMBL841213 0.57
SCHEMBL9902572 0.57
SCHEMBL6269262 0.57
SCHEMBL6297223 0.56
SCHEMBL5036932 0.54
SCHEMBL17581074 0.49
SCHEMBL8758 0.48
SCHEMBL246873 0.48
SCHEMBL895220 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080047837-A1 Method for anodizing aluminum-copper alloy BIRSS VIOLA I 2008-02-28 US claimed
EP-0807857-B1 Electrophotographic elements containing preferred pigment particle size distribution EASTMAN KODAK CO (US) 2003-07-30 EP claimed
US-7435524-B2 Permanent, removable tissue markings THE GENERAL HOSPTIAL CORPORATION (US) 2008-10-14 US disclosed
EP-1682085-A4 VARIABLE APPEARANCE TISSUE MARKINGS GEN HOSPITAL CORP (US) 2008-06-04 EP disclosed
WO-2008027835-A1 METHOD FOR ANODIZING ALUMINUM-COPPER ALLOY UTI LIMITED PARTNERSHIP (CA) 2008-03-06 WO disclosed
US-20080047837-A1 Method for anodizing aluminum-copper alloy BIRSS VIOLA I 2008-02-28 US disclosed
US-20080044746-A1 PERMANENT, REMOVABLE TISSUE MARKINGS THE GENERAL HOSPITAL CORPORATION 2008-02-21 US disclosed
US-7285364-B2 Permanent, removable tissue markings THE GENERAL HOSPITAL CORPORATION (US) 2007-10-23 US disclosed
US-20070107625-A1 Permanent, removable tissue markings THE GENERAL HOSPITAL CORPORATION 2007-05-17 US disclosed
US-7175950-B2 Permanent, removable tissue markings THE GENERAL HOSPITAL CORPORATION (US) 2007-02-13 US disclosed
EP-1682085-A2 VARIABLE APPEARANCE TISSUE MARKINGS THE GENERAL HOSPITAL CORPORATION (US) 2006-07-26 EP disclosed
WO-2005046620-A2 VARIABLE APPEARANCE TISSUE MARKINGS THE GENERAL HOSPITAL CORPORATION (US) 2005-05-26 WO disclosed
US-6881249-B2 Permanent, removable tissue markings THE GENERAL HOSPITAL CORPORATION (US) 2005-04-19 US disclosed
US-6814760-B2 Permanent, removable tissue markings THE GENERAL HOSPITAL CORPORATION 2004-11-09 US disclosed
US-6800122-B2 OBTAINING COLORED MICROPARTICLES EACH COMPRISING A CHROMOPHORE AND HAVING A SPECIFIC PROPERTY THAT IS DESIGNED IN ADVANCE TO ENABLE THE MICROPARTICLES TO BE ALTERED WHEN EXPOSED TO A SPECIFIC ENERGY; AND IMPLANTING INTO THE TISSUE FREEDOM-2, LLC 2004-10-05 US disclosed
US-20030167964-A1 Permanent, removable tissue markings FREEDOM-2, INC. 2003-09-11 US disclosed
US-20030159615-A1 Permanent, removable tissue markings FREEDOM-2, INC. 2003-08-28 US disclosed
US-20030113540-A1 2-NITRO-P-PHENYLENE DIAMINE DERIVATIVES AS SUBSTANTIVE DYE: WATER SOLUBILITY OR DISPERSIBILITY; REDUCING AND OXIDIZING AGENT STABILITY THE GENERAL HOSPITAL CORPORATION, A MASSACHUSETTS CORPORATION 2003-06-19 US disclosed
EP-1131038-A1 PERMANENT, REMOVABLE TISSUE MARKINGS THE GENERAL HOSPITAL CORPORATION (US) 2001-09-12 EP disclosed
WO-2000030592-A1 PERMANENT, REMOVABLE TISSUE MARKINGS THE GENERAL HOSPITAL CORPORATION (US) 2000-06-02 WO disclosed